文献速递免疫规划卫生政策与健康促进

加拿大安大略省2015至2020年COVID-19疫苗相关特殊关注不良事件的背景发生率:为COVID-19疫苗安全性监测提供依据

Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance.
PubMed 文献 · Vaccine · 2022-04-27

本研究基于加拿大安大略省关联健康行政数据库,开展人群回顾性观察研究,估计2015-2019年及2020年11种COVID-19疫苗相关特殊关注不良事件的背景发生率。结果显示2015-2019年急性心肌梗死年均发生率为191/10万,特发性血小板减少症为43.9/10万,过敏性休克为28.8/10万,贝尔麻痹为27.8/10万,热性惊厥为25.0/10万,急性播散性脑脊髓炎为22.8/10万,心肌炎/心包炎为11.3/10万,心包炎为8.7/10万,心肌炎为2.9/10万,川崎病为2.0/10万,吉兰-巴雷综合征为1.9/10万,横贯性脊髓炎为1.7/10万。女性急性播散性脑脊髓炎、横贯性脊髓炎和过敏性休克发生率较高,男性心肌炎、心包炎和吉兰-巴雷综合征发生率较高。贝尔麻痹、急性播散性脑脊髓炎和吉兰-巴雷综合征随年龄增长而增加。心肌炎和/或心包炎平均发生率随年龄增长至79岁;男性发生率高于女性:心肌炎为12至59岁,心包炎为≥12岁。热性惊厥和川崎病主要为儿童疾病,随年龄增长而降低。结论认为这些估计的背景发生率将有助于估计这些疾病的预期事件数,并促进COVID-19疫苗接种后潜在安全信号的检测。

要点

  • 2015-2019年安大略省11种特殊关注不良事件的背景发生率已估计,如急性心肌梗死191/10万、特发性血小板减少症43.9/10万。
  • 女性急性播散性脑脊髓炎、横贯性脊髓炎和过敏性休克发生率较高,男性心肌炎、心包炎和吉兰-巴雷综合征发生率较高。
  • 贝尔麻痹、急性播散性脑脊髓炎和吉兰-巴雷综合征随年龄增长而增加;心肌炎和/或心包炎平均发生率随年龄增长至79岁。

核心结论

  • 估计的背景发生率将有助于估计这些疾病的预期事件数,并促进COVID-19疫苗接种后潜在安全信号的检测。

研究设计与样本

  • 基于人群的回顾性观察研究,使用关联健康行政数据库,纳入安大略省居民住院和急诊就诊数据,估计2015-2019年及2020年11种特殊关注不良事件的发生率。

主要发现

  • 2015-2019年期间每10万人口年均发生率:急性心肌梗死191,特发性血小板减少症43.9,过敏性休克28.8,贝尔麻痹27.8,热性惊厥25.0,急性播散性脑脊髓炎22.8,心肌炎/心包炎11.3,心包炎8.7,心肌炎2.9,川崎病2.0,吉兰-巴雷综合征1.9,横贯性脊髓炎1.7。
  • 女性急性播散性脑脊髓炎、横贯性脊髓炎和过敏性休克发生率较高,男性心肌炎、心包炎和吉兰-巴雷综合征发生率较高。
  • 贝尔麻痹、急性播散性脑脊髓炎和吉兰-巴雷综合征随年龄增长而增加;心肌炎和/或心包炎平均发生率随年龄增长至79岁。
  • 男性心肌炎发生率高于女性:12至59岁;男性心包炎发生率高于女性:≥12岁。
  • 热性惊厥和川崎病主要为儿童疾病,随年龄增长而降低。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Background incidence rates are critical in pharmacovigilance to facilitate identification of vaccine safety signals. We estimated background incidence rates of 11 adverse events of special interest related to COVID-19 vaccines in Ontario, Canada. METHODS: We conducted a population-based retrospective observational study using linked health administrative databases for hospitalizations and emergency department visits among Ontario residents. We estimated incidence rates of Bell's palsy, idiopathic thrombocytopenia, febrile convulsions, acute disseminated encephalomyelitis, myocarditis, pericarditis, Kawasaki disease, Guillain-Barré syndrome, transverse myelitis, acute myocardial infarction, and anaphylaxis during five pre-pandemic years (2015-2019) and 2020. RESULTS: The average annual population was 14 million across all age groups with 51% female. The pre-pandemic mean annual rates per 100,000 population during 2015-2019 were 191 for acute myocardial infarction, 43.9 for idiopathic thrombocytopenia, 28.8 for anaphylaxis, 27.8 for Bell's palsy, 25.0 for febrile convulsions, 22.8 for acute disseminated encephalomyelitis, 11.3 for myocarditis/pericarditis, 8.7 for pericarditis, 2.9 for myocarditis, 2.0 for Kawasaki disease, 1.9 for Guillain-Barré syndrome, and 1.7 for transverse myelitis. Females had higher rates of acute disseminated encephalomyelitis, transverse myelitis and anaphylaxis while males had higher rates of myocarditis, pericarditis, and Guillain-Barré syndrome. Bell's palsy, acute disseminated encephalomyelitis, and Guillain-Barré syndrome increased with age. The mean rates of myocarditis and/or pericarditis increased with age up to 79 years; males had higher rates than females: from 12 to 59 years for myocarditis and ≥12 years for pericarditis. Febrile convulsions and Kawasaki disease were predominantly childhood diseases and generally decreased with age. CONCLUSIONS: Our estimated background rates will permit estimating numbers of expected events for these conditions and facilitate detection of potential safety signals following COVID-19 vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Nasreen S, Calzavara A, Buchan SA, et al. Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance. Vaccine. 2022. PMID: 35527057. doi:10.1016/j.vaccine.2022.04.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。